# CD58
## Overview

CD58, also known as lymphocyte function-associated antigen 3 (LFA-3), is crucial for immune recognition, facilitating interactions between tumor cells and cytotoxic T cells and natural killer (NK) cells. In DLBCL, mutations prevent the expression of CD58 on the cell surface, impairing the ability of T and NK cells to recognize and attack the tumor cells. This is often accompanied by mutations in the β2-Microglobulin gene, which further aids in immune evasion.<sup>1</sup>
## History
```mermaid
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
    title Publication timing
      2011-07-27 : Morin : DLBCL
      2015-10-01 : Schneider : PMBL
```
## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
|![DLBCL](images/icons/DLBCL_tier1.png) |1   |high-confidence DLBCL gene            |

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source               |frequency (%)|
|:------:|:---------------------:|:-------------:|
|DLBCL |GAMBL genomes        | 7.84        |
|DLBCL |Schmitz cohort       |10.00        |
|DLBCL |Reddy cohort         | 2.80        |
|DLBCL |Chapuy cohort        | 6.84        |
|BL    |GAMBL genomes+capture| 0.92        |
|BL    |Thomas cohort        | 0.80        |
|BL    |Panea cohort         | 2.00        |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |3.10            | 32.536         |
|DLBCL |No  |Yes                  |8.62            |292.453         |
|FL    |No  |Yes                  |0.00            |107.458         |


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CD58_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CD58_protein_hg38.html)

![image](images/proteinpaint/CD58_NM_001779.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CD58.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CD58_hg38.html)

![image](images/proteinpaint/CD58.svg)

## CD58 Expression
![image](images/gene_expression/CD58_by_pathology.svg)

## References

1. *Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R. Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011 Dec 13;20(6):728-40. doi: 10.1016/j.ccr.2011.11.006. Epub 2011 Dec 1. PMID: 22137796; PMCID: PMC3660995.*
2. *Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298-303. doi: 10.1038/nature10351. PMID: 21796119; PMCID: PMC3210554.*
<!-- ORIGIN: morinFrequentMutationHistonemodifying2011 -->
